Enrollment closed • Enrollment change • Trial completion date • Trial primary completion date
|
HER-2 (Human epidermal growth factor receptor 2) • SCGB2A2 (Secretoglobin Family 2A Member 2)
|
HER-2 amplification • HER-2 negative
|
mammaglobin-A DNA vaccine